Bevacizumab (Avastin) IV Solution from Germany
Bevacizumab is a humanized monoclonal antibody blocking VEGF, used for colorectal and lung cancer. Under HTS 3002.15.00.11 for its role in immunological regulation via angiogenesis inhibition, in retail-measured vials.
Duty Rate — Germany → United States
0%
Rate breakdown
9903.05.860%Universal product exemption (U.S. note 52(b))
Import Tips
• Include VEGF specificity test results and monoclonal purity assays in import docs
• Comply with USP <1079> for good distribution practices; avoid temperature excursions